Abstract
QUESTION: I prescribed misoprostol to one of my patients with a peptic ulcer. When she found out she was pregnant while on the drug, both she and, admittedly, I were very scared to learn that the drug is teratogenic in that it causes Möbius syndrome. How great is the risk? ANSWER: Very small. Although women who use misoprostol during the first trimester have a 30-fold higher risk of having babies with Möbius syndrome, the malformation is so rare that, even if you see 1000 women who took misoprostol during embryogenesis, you might not see a single child with the syndrome. It is crucial to explain the size of the risk; otherwise women tend to believe the risk is huge even when, in fact, it is hardly measurable.
Full Text
The Full Text of this article is available as a PDF (21.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Khattak S., K-Moghtader G., McMartin K., Barrera M., Kennedy D., Koren G. Pregnancy outcome following gestational exposure to organic solvents: a prospective controlled study. JAMA. 1999 Mar 24;281(12):1106–1109. doi: 10.1001/jama.281.12.1106. [DOI] [PubMed] [Google Scholar]
- Koren G., Bologa M., Long D., Feldman Y., Shear N. H. Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1190–1194. doi: 10.1016/0002-9378(89)90186-5. [DOI] [PubMed] [Google Scholar]
- Koren G., Pastuszak A., Ito S. Drugs in pregnancy. N Engl J Med. 1998 Apr 16;338(16):1128–1137. doi: 10.1056/NEJM199804163381607. [DOI] [PubMed] [Google Scholar]
- Pastuszak A. L., Schüler L., Speck-Martins C. E., Coelho K. E., Cordello S. M., Vargas F., Brunoni D., Schwarz I. V., Larrandaburu M., Safattle H. Use of misoprostol during pregnancy and Möbius' syndrome in infants. N Engl J Med. 1998 Jun 25;338(26):1881–1885. doi: 10.1056/NEJM199806253382604. [DOI] [PubMed] [Google Scholar]
- Schüler L., Pastuszak A., Sanseverino T. V., Orioli I. M., Brunoni D., Ashton-Prolla P., Silva da Costa F., Giugliani R., Couto A. M., Brandao S. B. Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study. Reprod Toxicol. 1999 Mar-Apr;13(2):147–151. doi: 10.1016/s0890-6238(98)00072-0. [DOI] [PubMed] [Google Scholar]